Connection

MICHAEL R MIGDEN to Clinical Protocols

This is a "connection" page, showing publications MICHAEL R MIGDEN has written about Clinical Protocols.
Connection Strength

0.584
  1. CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma. Future Oncol. 2020 Feb; 16(4):11-19.
    View in: PubMed
    Score: 0.584
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.